Low dose naltrexone (LDN) is becoming more and more widely used in fibromyalgia (FM) and chronic fatigue syndrome (ME/CFS). You can chart that use right back to Jarred Younger’s two small FM trials in 2009 and 2013. Now Younger’s back with a third trial...
The last of three blogs on The Solve ME/CFS Initiative focuses on the SMCI’s core mission – funding research that makes a difference in chronic fatigue syndrome (ME/CFS). Serendipity can play a major role in research and it may be doing so at the SMCI....
Inflammation – Neuro and Otherwise Inflammation has become an increasingly important topic in fibromyalgia. It’s clear that “central sensitization” – an increase in pain sensitivity engineered by the central nervous system – is...
A Different Look at the Immune System The ultimate goal of this work is the development of a non-subjective clinical tool for diagnosing patients with ME. Lombardi et. al. Last month Health Rising looked at a potential ion channel biomarker coming out of the NCNED in...
Hot Story The media reports have been sizzling! Griffith University, the home of the NCNED group in Australia that produced the study, called it “groundbreaking”. IFL Science lead off with a piece called “People With Chronic Fatigue Have A Defective...
Dr. Light has said that he wants to do for fatigue what researchers have done for pain; that is uncover the molecular pathways that cause fatigue. Some time ago Light presented one of the most spectacular graphs of ME/CFS ever done. I still remember the gasp that...
Keep the information flowing! Support Health Rising during our quickie Summer Donation Drive!Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.